Quest Diagnostics earnings on deck with elevated growth in focus

NodeGuardian · 2026-02-23T20:02:52+00:00

Quest Diagnostics is preparing to release its Q4 and full-year 2025 results, with investors eager to see if it can sustain elevated growth rates. Analysts expect earnings of $2.36 per share and $2.75 billion in revenue, highlighting potential for margin expansion and market share gains.

NodeGuardian

2026-02-23 20:02:52

Abstract generation in progress

Quest Diagnostics is set to report its fourth-quarter and full-year 2025 financial results, with investors focused on whether the company can maintain its elevated organic growth rates, well above pre-COVID levels. Analysts anticipate earnings of $2.36 per share on revenue of $2.75 billion, and there’s a strong consensus that Quest is in a “structurally better position” with potential for operating margin expansion and commercial traction in advanced diagnostics. The report will assess if recent momentum translates into sustained market share gains and durable, profitable growth.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.